MedTrace Logo

Investigation of Novel Non-CE Marked Catheter

NCT06451796 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2024-06-21

No results posted yet for this study

Summary

Hypothesis: Treatment with the hydrophilic coated valved intraurethral catheter up to 16 hours per day is effective, well tolerated and seemingly safe for treatment of women with stress incontinence.

Test persons: Ten to twenty stress incontinent women. Treatment time: Up to two weeks

Conditions

  • Female Stress Incontinence

Interventions

DEVICE

Obtinu

Treatment of Female Stress Incontinence with a hydrophilic coated valved intraurethral catheter

Sponsors & Collaborators

  • Herlev Hospital

    collaborator OTHER

  • MagCath

    lead UNKNOWN

Principal Investigators

  • Pia Sander, MD PhD · Herlev Hospital

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-06-18
Primary Completion
2024-09-30
Completion
2024-09-30

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06451796 on ClinicalTrials.gov